ERBB2 and metabolic dysfunction-associated steatotic liver disease: Moreover, the correlation between this metabolite and TRIP6 and ERBB2, two genes that were recently identified to play a role in the pathophysiology of NAFLD (Machado et al., 2015; Wang et al., 2016), suggests that upregulation of these genes can be induced via circulating metabolites.